{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T11:47:04Z","timestamp":1791287224382,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1016\/j.ajog.2013.04.014","type":"journal-article","created":{"date-parts":[[2013,4,10]],"date-time":"2013-04-10T10:35:04Z","timestamp":1365590104000},"page":"142.e1-142.e6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"title":["Predictive value of serum human epididymis protein 4 and cancer antigen 125 concentrations in endometrial carcinoma"],"prefix":"10.1016","volume":"209","author":[{"given":"Sami K.","family":"Saarelainen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Peltonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terho","family":"Lehtim\u00e4ki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antti","family":"Perheentupa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maarit H.","family":"Vuento","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna U.","family":"M\u00e4enp\u00e4\u00e4","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2013.04.014_bib1","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1097\/AOG.0b013e318162f690","article-title":"Endometrial cancer","volume":"111","author":"Sorosky","year":"2008","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2013.04.014_bib2","doi-asserted-by":"crossref","first-page":"165","DOI":"10.4143\/crt.2007.39.4.165","article-title":"MR imaging in endometrial carcinoma as a diagnostic tool for the prediction of myometrial invasion and lymph node metastasis","volume":"39","author":"Ryoo","year":"2007","journal-title":"Cancer Res Treat"},{"key":"10.1016\/j.ajog.2013.04.014_bib3","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/j.1525-1438.2007.00805.x","article-title":"Evaluation of endometrial carcinoma on magnetic resonance imaging","volume":"17","author":"Rockall","year":"2007","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ajog.2013.04.014_bib4","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1200\/JCO.2011.38.2416","article-title":"Preoperative identification of a low-risk group for lymph node metastasis in endometrial cancer: a Korean gynecologic oncology group study","volume":"30","author":"Kang","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ajog.2013.04.014_bib5","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1002\/ijc.26433","article-title":"The utility of serum CA-125 in predicting extra-uterine disease in apparent early-stage endometrial cancer","volume":"131","author":"Nicklin","year":"2012","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ajog.2013.04.014_bib6","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ygyno.2010.04.018","article-title":"Evaluation of serum CA-125 levels for preoperative counseling in endometrioid endometrial cancer: a multi-center study","volume":"118","author":"Kim","year":"2010","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ajog.2013.04.014_bib7","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1095\/biolreprod45.2.350","article-title":"A\u00a0major human epididymis-specific cDNA encodes a protein with sequence homology to extracellular proteinase inhibitors","volume":"45","author":"Kirchhoff","year":"1991","journal-title":"Biol Reprod"},{"key":"10.1016\/j.ajog.2013.04.014_bib8","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S1470-2045(06)70579-4","article-title":"Proteins with whey-acidic-protein motifs and cancer","volume":"7","author":"Bouchard","year":"2006","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ajog.2013.04.014_bib9","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1007\/s13277-012-0356-9","article-title":"Serum HE4 as a diagnostic and prognostic marker for lung cancer","volume":"33","author":"Iwahori","year":"2012","journal-title":"Tumour Biol"},{"key":"10.1016\/j.ajog.2013.04.014_bib10","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.humpath.2012.07.017","article-title":"Human epididymis protein 4 is up-regulated in gastric and pancreatic adenocarcinomas","volume":"44","author":"O'Neal","year":"2013","journal-title":"Hum Pathol"},{"key":"10.1016\/j.ajog.2013.04.014_bib11","first-page":"4779","article-title":"HE4\u00a0expression can be associated with lymph node metastases and disease-free survival in\u00a0breast cancer","volume":"30","author":"Kamei","year":"2010","journal-title":"Anticancer Res"},{"key":"10.1016\/j.ajog.2013.04.014_bib12","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.ygyno.2008.04.002","article-title":"Utility of a novel serum tumor biomarker HE4 in patients with endometrioid adenocarcinoma of the uterus","volume":"110","author":"Moore","year":"2008","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ajog.2013.04.014_bib13","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1097\/IGC.0b013e3182229ad8","article-title":"Utility of tumor marker HE4 to predict depth of myometrial invasion in endometrioid adenocarcinoma of the uterus","volume":"21","author":"Moore","year":"2011","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ajog.2013.04.014_bib14","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.ygyno.2011.10.025","article-title":"Correlation of serum HE4 with tumor size and myometrial invasion in endometrial cancer","volume":"124","author":"Kalogera","year":"2012","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ajog.2013.04.014_bib15","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ygyno.2008.08.031","article-title":"A\u00a0novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass","volume":"112","author":"Moore","year":"2009","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ajog.2013.04.014_bib16","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1038\/sj.bjc.6605011","article-title":"Serum HE4 concentration differentiates malignant ovarian tumours from ovarian endometriotic cysts","volume":"100","author":"Huhtinen","year":"2009","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ajog.2013.04.014_bib17","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.ygyno.2009.10.050","article-title":"The new FIGO staging system for cancers of the vulva, cervix, endometrium and sarcomas","volume":"115","author":"Mutch","year":"2009","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ajog.2013.04.014_bib18","doi-asserted-by":"crossref","first-page":"3668","DOI":"10.1200\/JCO.2005.04.144","article-title":"Retrospective analysis of selective lymphadenectomy in apparent early-stage endometrial cancer","volume":"23","author":"Cragun","year":"2005","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ajog.2013.04.014_bib19","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1002\/cncr.22185","article-title":"Therapeutic role of lymph node resection in endometrioid corpus cancer: a study of 12,333 patients","volume":"107","author":"Chan","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.ajog.2013.04.014_bib20","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1097\/01.AOG.0000149151.74863.c4","article-title":"Surgical staging for patients presenting with grade 1 endometrial carcinoma","volume":"105","author":"Ben-Shachar","year":"2005","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2013.04.014_bib21","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1093\/jnci\/djn397","article-title":"Systematic pelvic lymphadenectomy vs no lymphadenectomy in early-stage endometrial carcinoma: Randomized clinical trial","volume":"100","author":"Benedetti Panici","year":"2008","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.ajog.2013.04.014_bib22","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0140-6736(08)61766-3","article-title":"Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study","volume":"373","author":"Kitchener","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2013.04.014_bib23","doi-asserted-by":"crossref","first-page":"216.e1","DOI":"10.1016\/j.ajog.2007.08.028","article-title":"Prognostic factors and risk of extrauterine metastases in 3867 women with grade 1 endometrioid corpus cancer","volume":"198","author":"Chan","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2013.04.014_bib24","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1525-1438.2007.00996.x","article-title":"The incidence of pelvic lymph node metastasis by FIGO staging for patients with adequately surgically staged endometrial adenocarcinoma of endometrioid histology","volume":"18","author":"Chi","year":"2008","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ajog.2013.04.014_bib25","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1038\/bjc.2011.109","article-title":"Diagnostic and prognostic impact of serum HE4 detection in endometrial carcinoma patients","volume":"104","author":"Bignotti","year":"2011","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ajog.2013.04.014_bib26","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.ygyno.2012.04.022","article-title":"HE4 is an independent prognostic marker in endometrial cancer patients","volume":"126","author":"Mutz-Dehbalaie","year":"2012","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ajog.2013.04.014_bib27","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s13277-012-0583-0","article-title":"The role of novel biomarker HE4 in endometrial cancer: a case control prospective study","volume":"24","author":"Angioli","year":"2013","journal-title":"Tumour Biol"},{"key":"10.1016\/j.ajog.2013.04.014_bib28","doi-asserted-by":"crossref","first-page":"349.e1","DOI":"10.1016\/j.ajog.2011.12.028","article-title":"Serum levels of\u00a0the ovarian cancer biomarker HE4 are decreased in pregnancy and increase with age","volume":"206","author":"Moore","year":"2012","journal-title":"Am\u00a0J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2013.04.014_bib29","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s13277-011-0256-4","article-title":"Human epididymis protein 4 reference limits and natural variation in a Nordic reference population","volume":"33","author":"Bolstad","year":"2012","journal-title":"Tumour Biol"},{"key":"10.1016\/j.ajog.2013.04.014_bib30","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1177\/1403494807088453","article-title":"Cross-sectional study on\u00a0the relationship between body mass index and smoking, and longitudinal changes in body mass index in relation to change in smoking status: the Tromso study","volume":"36","author":"Sneve","year":"2008","journal-title":"Scand J Public Health"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937813003633?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937813003633?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T10:52:29Z","timestamp":1757587949000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937813003633"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["S0002937813003633"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2013.04.014","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2013,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Predictive value of serum human epididymis protein 4 and cancer antigen 125 concentrations in endometrial carcinoma","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2013.04.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}